Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

FLXN Company Profile and Key Details

NASDAQ : FLXN

Flexion Therapeutics

$25.15
0.0403+0.16%
At Close 4:00 PM
Not Actively Trading
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Horizon Flexible Income ETF (FLXN) stock surged +0.16%, trading at $25.15 on CBOE, up from the previous close of $25.11. The stock opened at $25.19, fluctuating between $25.15 and $25.19 in the recent session.

Stock Snapshot

25.1097
Prev. Close
1.26B
Market Cap
25.15
Day Low
N/A
P/E Ratio
N/A
EPS (TTM)
N/A
Cash Flow per Share
25.19
Open
50.27M
Number of Shares
25.19
Day High
N/A
Free Float in %
N/A
Book Value
1.28M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 31, 202525.1925.1925.1525.151.28M
Jul 30, 202525.1325.1325.1125.11100
Jul 22, 202525.1425.1425.1425.140
Jul 17, 202525.0025.0024.9924.99200
Jul 16, 202525.0025.0024.9224.92200
Jul 15, 202525.0025.0024.9924.99200
Jul 14, 202525.0025.0024.9924.99200
Jul 10, 202525.0525.0524.9925.024.41K
Jul 08, 202524.9424.9424.9424.94100

Contact Details

Burlington, MA 01803

United States

http://www.flexiontherapeutics.com178 130 57777

About Company

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201, a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, an administered NaV1.7 inhibitor for the management of post-operative pain. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.

Company Information

Employees257
Beta1.53
Sales or RevenueN/A
5Y Sales Change%N/A
Fiscal Year EndsN/A
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Frequently Asked Questions

What is the current Flexion Therapeutics, Inc. (FLXN) stock price?
Flexion Therapeutics, Inc. (NASDAQ: FLXN) stock price is $25.15 in the last trading session. During the trading session, FLXN stock reached the peak price of $25.19 while $25.15 was the lowest point it dropped to. The percentage change in FLXN stock occurred in the recent session was 0.16% while the dollar amount for the price change in FLXN stock was $0.04.
FLXN's industry and sector of operation?
The NASDAQ listed FLXN is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Flexion Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of FLXN?
No Data
How FLXN did perform over past 52-week?
FLXN's closing price is 0.92% higher than its 52-week low of $24.92 where as its distance from 52-week high of $25.20 is -0.16%.
How many employees does FLXN have?
Number of FLXN employees currently stands at 257.
Link for FLXN official website?
Official Website of FLXN is: http://www.flexiontherapeutics.com
How do I contact FLXN?
FLXN could be contacted at phone 178 130 57777 and can also be accessed through its website. FLXN operates from 10 Mall Rd Ste 301, Burlington, MA 01803, United States.
How many shares of FLXN are traded daily?
FLXN stock volume for the day was 1.28M shares. The average number of FLXN shares traded daily for last 3 months was 71.45K.
What is the market cap of FLXN currently?
The market value of FLXN currently stands at $1.26B with its latest stock price at $25.15 and 50.27M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph